MAH Holding Services
In 2017, China introduced the "Marketing Authorization Holder (MAH)" system for drugs, opening a door for R&D institutions and researchers to own their own drugs. At the same time, it also requires them to assume a series of corresponding legal responsibilities — covering the entire drug lifecycle: from R&D, supply chain management, manufacturing (with contract manufacturers), distribution and sales, adverse reaction monitoring, product lifecycle management, to product registration changes and renewals.
Each of these stages demands a professional, qualified, and experienced team, as well as well-established physical resources, management systems, and operational systems. For R&D institutions and researchers, as the owners of drugs MAH, taking on these legal responsibilities is mandatory — but also highly challenging.
Kangchuanji helps you realize your dream of bringing your research results to market. For more details, please contact our BD Manager.
Keywords：
MAH Holding Services
Recommended Products
Product Consultation
If you have any suggestions, please leave a message or send us an email. We will reply to you within one working day after receiving your message.
Please contact us for more detailed information.
Kangchuanji Pharmatech looks forward to working with you and jointly creating a bright future!
Follow us
Nanjing Kangchuanji Pharmatech Co., Ltd.
Contact Us：18020149597（HR）
Recruitment Email:recruit@kcjpharma.com
Address: 2nd Floor, Building 5, No.199 Wenfang Road, Jiangning District, Nanjing, Jiangsu Province, China（Jiangning High-tech Park）
Copyright © Nanjing Kangchuanji Pharmatech Co., Ltd.